BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,322,000 | -42.4% | 1,250,000 | -44.4% | 0.00% | -50.0% |
| Q1 2018 | $2,295,000 | -5.7% | 2,250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,434,000 | +14.0% | 2,250,000 | +19.0% | 0.00% | -42.9% |
| Q1 2017 | $2,135,000 | +1.0% | 1,890,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $2,113,000 | -6.8% | 1,890,000 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $2,267,000 | +8.0% | 1,890,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $2,099,000 | -4.1% | 1,890,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $2,189,000 | -9.8% | 1,890,000 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $2,426,000 | -0.7% | 1,890,000 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $2,442,000 | -47.6% | 1,890,000 | -37.5% | 0.01% | -41.2% |
| Q2 2015 | $4,662,000 | -21.7% | 3,025,000 | -24.4% | 0.02% | -19.0% |
| Q1 2015 | $5,952,000 | +26.6% | 4,000,000 | 0.0% | 0.02% | +23.5% |
| Q4 2014 | $4,702,000 | +11.0% | 4,000,000 | 0.0% | 0.02% | +6.2% |
| Q3 2014 | $4,235,000 | +2.3% | 4,000,000 | 0.0% | 0.02% | 0.0% |
| Q2 2014 | $4,138,000 | -5.6% | 4,000,000 | 0.0% | 0.02% | -5.9% |
| Q1 2014 | $4,383,000 | – | 4,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|